Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 15/20 | 0.67 |
| ▸ | CA12 | O43570 | 14/20 | 0.67 |
| ▸ | CA1 | P00915 | 9/20 | 0.67 |
| ▸ | SERPINE1 | P05121 | 5/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.56 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.56 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.56 |
| ▸ | UGT1A7 | Q9HAW7 | 1/20 | 0.56 |
| ▸ | SLC22A11 | Q9NSA0 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6349618 | 0.85 | SERPINE1 (0.53) | CA9CA12CA1SERPINE1CA2 | |
| SCHEMBL6824792 | 0.84 | CA9 (0.74) | CA9CA12CA1CA2RAB9A | |
| Hydrochloric Acid SCHEMBL6346555 | 0.84 | SERPINE1 (0.52) | CA9CA12CA1SERPINE1CA2 | |
| Hydrochloric Acid SCHEMBL6358891 | 0.84 | SERPINE1 (0.52) | CA9CA12CA1SERPINE1CA2 | |
| SCHEMBL6357624 | 0.83 | CA12 (0.52) | CA9CA12CA1SERPINE1RAB9A | |
| SCHEMBL6825234 | 0.83 | CA9 (0.66) | CA9CA12CA1CA2RAB9A | |
| SCHEMBL6821696 | 0.81 | CA9 (0.64) | CA9CA12CA1CA2RAB9A | |
| SCHEMBL2885883 | 0.80 | CA9 (0.60) | CA9CA12CA1CA2SMN1; SMN2 | |
| SCHEMBL2892747 | 0.80 | CA9 (0.58) | CA9CA12CA1CA2RAB9A | |
| SCHEMBL2893220 | 0.78 | CA9 (0.55) | CA9CA12CA1CA2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | claimed |
| US-20050113450-A1 | Antibacterial agents | PHARMACIA & UPJOHN COMPANY | 2005-05-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113450-A1 | Antibacterial agents | CLPP, SPOUT1, SAMHD1 | CA9 2085/4885CA12 3717/4885CA1 4266/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.